Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Seeing the world as animals do: How to leverage generative AI for ecological neuroscience
Generative artificial intelligence will offer a new way to see, simulate and hypothesize about how animals experience their worlds. In doing so, it could help bridge the long-standing gap between neural function and behavior.
Seeing the world as animals do: How to leverage generative AI for ecological neuroscience
Generative artificial intelligence will offer a new way to see, simulate and hypothesize about how animals experience their worlds. In doing so, it could help bridge the long-standing gap between neural function and behavior.
Psilocybin rewires specific mouse cortical networks in lasting ways
Neuronal activity induced by the psychedelic drug strengthens inputs from sensory brain areas and weakens cortico-cortical recurrent loops.
Psilocybin rewires specific mouse cortical networks in lasting ways
Neuronal activity induced by the psychedelic drug strengthens inputs from sensory brain areas and weakens cortico-cortical recurrent loops.
Home makeover helps rats better express themselves: Q&A with Raven Hickson and Peter Kind
The “Habitat”—a complex environment with space for large social groups—expands the behavioral repertoire of rodent models, Hickson and Kind say.
Home makeover helps rats better express themselves: Q&A with Raven Hickson and Peter Kind
The “Habitat”—a complex environment with space for large social groups—expands the behavioral repertoire of rodent models, Hickson and Kind say.